Who Owns AEON?

AEON Biopharma, Inc. — Institutional Ownership & 13F Holdings

$0.99

-0.05 (-4.80%)

Market Cap

$12.7M

Shares Outstanding

11,830,339

Institutional Holders

15

Total Inst. Value

$884K

% of Float Held

QoQ Holder Change

-31

Institutional data as of Q1 2025

New Positions

3

Closed Positions

25

Increased

1

Decreased

11

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Dauntless Investment Group, LLCNew$594K1,025,000
2SABBY MANAGEMENT, LLCNew$261K449,687
3Blue Owl Capital Holdings LP$25K42,353
4BlackRock, Inc.$2K3,671
5UBS Group AG$2K2,957
6BANK OF AMERICA CORP /DE/$1K2,319
7DUPONT CAPITAL MANAGEMENT CORP$99170
8SBI Securities Co., Ltd.$61106
9Steward Partners Investment Advisory, LLC$58100
10WELLS FARGO & COMPANY/MN$5290

Biggest Buyers & Sellers This Quarter

Top Buyers

Related Stocks

Frequently Asked Questions

How many institutional investors hold AEON?

As of Q1 2025, 15 institutional investors report holding AEON (AEON Biopharma, Inc.) in their 13F filings.

Which hedge fund owns the most AEON?

The largest institutional holder of AEON is Dauntless Investment Group, LLC with $594K in shares.

Are institutions buying or selling AEON?

This quarter, 3 institutions opened new positions in AEON and 25 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.